Skip to main content
Remedy Entertainment Oyj logo

Remedy Entertainment Oyj — Investor Relations & Filings

Ticker · REMEDY ISIN · FI4000251897 LEI · 7437003VZ3JPF7DBTG92 HE Publishing, broadcasting, and content production and distribution activities
Open in API
Filings indexed 450 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country FI Finland
Listing HE REMEDY

About Remedy Entertainment Oyj

https://www.remedygames.com/

Remedy Entertainment is an independent game development studio founded in 1995, specializing in creating story-driven, cinematic third-person action games. The company is globally recognized for its visually stunning titles that blend intense action with deep, often supernatural, narratives. Its portfolio includes critically acclaimed and commercially successful franchises such as Max Payne, Alan Wake, and Control. The studio utilizes its proprietary Northlight game engine to build immersive worlds and deliver unique gameplay experiences. Remedy's core focus is on combining compelling storytelling with innovative game mechanics to create memorable interactive entertainment.

Recent filings

Filing Released Lang Actions
Remedy Entertainment Oyj: Remedy Entertainment Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release (“Pörssitiedote”) announcing the decisions taken at Remedy Entertainment Oyj’s Annual General Meeting (varsinaisen yhtiökokouksen päätökset) held on 21 May 2026. It details the voting results on the 2025 financial statements, discharge of liability, dividend decision, board composition and remuneration, auditor appointment, and share authorization resolutions. This is an official declaration of shareholder vote outcomes at an AGM, matching the Definition for Declaration of Voting Results & Voting Rights Announcements.
2026-05-21 Finnish
Remedy Entertainment Plc: Resolutions of Remedy Entertainment Plc's Annual General Meeting and the organizing meeting of the Board of Directors
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a stock exchange release summarizing the resolutions adopted at Remedy Entertainment Plc’s Annual General Meeting, including voting outcomes on financial statements, dividend distribution, board composition, auditor election, share repurchase and share issuance authorizations, and the organizing meeting of the Board. This matches the category for official results from shareholder votes at a general meeting.
2026-05-21 English
Remedy Q1 2026 Liiketoimintakatsaus.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed quarterly business review for Remedy Entertainment Oyj covering the period January to March 2026. It includes comprehensive financial data such as revenue, EBITDA, EBIT, cash flow, balance sheet items, and operational highlights. The text mentions the report is unaudited and provides management commentary on business performance, outlook, and strategic initiatives. It also references a webcast for the Q1 2026 earnings release. The presence of detailed financial statements and analysis for a quarter strongly indicates this is an Interim / Quarterly Report (IR). The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is IR with high confidence.
2026-05-05 Finnish
Remedy Entertainment Oyj: Liiketoimintakatsaus tammi-maaliskuu 2026: Remedy keskittyy ydinvahvuuksiinsa, CONTROL Resonant etenee suunnitellusti ja markkinointitoimet kiihtyvät
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Liiketoimintakatsaus tammi-maaliskuu 2026' which translates to 'Business Review January-March 2026'. It contains detailed financial data for the first quarter of 2026, including revenue, EBITDA, EBIT, cash flow, and other key financial metrics. It also includes management commentary on business performance, outlook, and operational highlights for the quarter. The document is explicitly described as 'tilintarkastamaton' (unaudited), which is typical for interim or quarterly reports. There is no indication that this is a full annual report or just an announcement of a report. The length (12,446 characters) and content confirm it is a substantive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-05-05 Finnish
Remedy Q1 2026 Business Review.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Business Review January–March 2026' and contains detailed financial data for the first quarter of 2026, including revenue, EBITDA, operating profit, cash flow, and balance sheet figures. It also includes management commentary by the CEO, outlook statements, and detailed operational and financial performance analysis for the quarter. The document is unaudited and covers a period shorter than a full fiscal year, specifically the first quarter. It is not a full annual report (10-K), nor is it an earnings release which typically contains only key highlights. The presence of comprehensive financial statements and analysis for a quarter indicates this is an Interim / Quarterly Report. The document is not an announcement of a report but the report itself, given its length (15,000 characters) and substantive content. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-05-05 English
Remedy Entertainment Plc: Business Review January-March 2026: Remedy is focusing on its core strengths, CONTROL Resonant on track and marketing activity ramping up
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Business Review January-March 2026' and contains detailed unaudited financial figures and operational commentary for the first quarter of 2026. It includes revenue, EBITDA, operating profit, cash flow, and other key financial metrics, as well as management commentary on business performance, product development, and outlook. The document is a comprehensive quarterly financial report with substantive financial data and analysis, not merely an announcement or summary. It is not a full annual report (10-K), but an interim or quarterly report covering a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-05-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.